$ARIA Recent News Hewlett-Packard, a cyclical green light

New Post Public Reply Private Reply Replies (0) Message Board

Dec 1, 2013 at 1:15 PM

$ARIA Recent News

Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Ariad soars as drug indexes move higher 12:47 p.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad rallies as drug indexes modestly rise 10:23 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Aria rockets on cancer drug data 9:38 a.m. Jan. 18, 2011 - Val Brickates Kennedy

Benzinga's Top #PreMarket Losers 7:19 a.m. Nov. 29, 2013 - benzinga.com
Four Biotech 'Surprise' Stocks for 2014 7:00 a.m. Nov. 27, 2013 - TheStreet.com
5 Biotechnology Stocks to Buy Now 7:00 a.m. Nov. 27, 2013 - InvestorPlace.com
Wednesday’s Biggest Stock Losers: BLOX, BRLI and More 5:10 a.m. Nov. 27, 2013 - InvestorPlace.com
Ariad Pharmaceuticals (ARIA) In A Perilous Reversal 11:50 a.m. Nov. 26, 2013 - TheStreet.com
Nuance and ARIAD Are Volume Movers for Very Different Reasons 11:24 a.m. Nov. 26, 2013 - 247WallSt.com
Ariad Pharma Appears Cheap Despite Reduced Opportunity 9:19 a.m. Nov. 26, 2013 - Seeking Alpha
Cramer's Lightning Round - What Happened With Ariad Was Jarring (11/25/13) 6:05 a.m. Nov. 26, 2013 - Seeking Alpha
'Mad Money' Lightning Round: Buy, Buy, Buy Splunk 6:00 a.m. Nov. 26, 2013 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: A Glass-Half-Full Market 8:25 p.m. Nov. 25, 2013 - TheStreet.com
Continuation of ARIAD's Iclusig in EU - Analyst Blog 5:00 p.m. Nov. 25, 2013 - Zacks.com
Market Wrap For November 25: Nasdaq Breaks 4,000 Level For First Time Since 2000 3:57 p.m. Nov. 25, 2013 - benzinga.com
ARIAD Shares Skyrocketing With 11 Positive Estimate Revisions 1:35 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Why Ariad Pharmaceuticals (ARIA) is Soaring 1:27 p.m. Nov. 25, 2013 - TheStreet.com
Trade-Ideas: Ariad Pharmaceuticals (ARIA) Is Today's "Barbarian At The Gate" Stock 12:36 p.m. Nov. 25, 2013 - TheStreet.com
3 Monday Morning Biotech Movers 12:15 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Strength Seen in Ariad Pharmaceuticals (ARIA): Stock Zooms 35.5% - Tale of the Tape 9:39 a.m. Nov. 25, 2013 - Zacks.com
Ariad Pharmaceuticals looks to extend Friday's rally 8:44 a.m. Nov. 25, 2013 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:12 a.m. Nov. 25, 2013 - benzinga.com
Mid-Afternoon Market Update: Markets on the Rise as Intel Falls 2:34 p.m. Nov. 22, 2013 - benzinga.com

Positive Opinion, Program Honorees, Positive Medical Results, and Investor Day - Research Report on Bristol-Myers Squibb, Ariad Pharmaceuticals, Dyax, Ironwood Pharmaceuticals, and Immunomedics 8:00 a.m. Nov. 27, 2013 - PR Newswire
Pre-Market Breakdown: Galena Biopharma Inc., Novavax Inc., Ariad Pharma Inc., and MannKind Corp. 8:00 a.m. Nov. 27, 2013 - PR Newswire
TrendingWallStreet.com Begins Market Coverage on NLY, VEND, ARIA, and FB 12:15 a.m. Nov. 27, 2013 - ACCESSWIRE
Must Watch Stocks: Ariad Pharmaceuticals, Hewlett-Packard Company, Camtek Ltd, Buka Ventures Inc 9:01 a.m. Nov. 26, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Analysis on BAC, NVGC, ARIA, and C 12:16 a.m. Nov. 26, 2013 - ACCESSWIRE
ARIA, SIRI, DVAX and UNXL added to NASDAQ Active Stock Watch List at GSR 10:10 a.m. Nov. 25, 2013 - ACCESSWIRE
TrendingWallStreet.com Initiates Coverage on ARIA, TXCC, SFTBY, and TWC 1:38 a.m. Nov. 25, 2013 - ACCESSWIRE
Law Offices of Howard G. Smith Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. -- ARIA 3:32 p.m. Nov. 22, 2013 - GlobeNewswire
ARIA, MU, AMRN and ARUN added to NASDAQ Active Stock Watch List at EPR 10:19 a.m. Nov. 22, 2013 - ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against ARIAD Pharmaceuticals, Inc. and Certain Officers - ARIA 8:00 a.m. Nov. 22, 2013 - PR Newswire
ARIAD Announces Positive Opinion by the European Medicines Agency on the Continued Availability of Iclusig in Patients with Leukaemias 7:46 a.m. Nov. 22, 2013 - BusinessWire
Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals 8:00 a.m. Nov. 20, 2013 - PR Newswire
Must Watch News & Earnings: Tesla Motors Inc, Pan Global Corp, Ariad Pharmaceuticals, Alpha Natural Resources, Brocade Communications Systems 10:23 a.m. Nov. 19, 2013 - PR Newswire
Appointments, Financial Results, Divestitures, and Staff Reductions- Research Report on AstraZeneca, VIVUS, Cooper, ARIAD, and Amarin 8:00 a.m. Nov. 13, 2013 - PR Newswire
Stock Analysis Reports on AMD, ARIA and GSAT 1:20 a.m. Nov. 13, 2013 - ACCESSWIRE
ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Nov. 12, 2013 - ACCESSWIRE
Shareholder Rights Law Firm Johnson & Weaver, LLP Files Derivative Lawsuit on behalf of ARIAD Pharmaceuticals, Inc. 9:29 a.m. Nov. 12, 2013 - BusinessWire
ARIAD Reports Third Quarter 2013 Financial Results and Announces Significant Expense Reduction 7:35 a.m. Nov. 12, 2013 - BusinessWire
Glancy Binkow & Goldberg Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. - ARIA 9:10 a.m. Nov. 11, 2013 - GlobeNewswire
News and Updates on ARIA, AFYG and ASAB 1:27 a.m. Nov. 8, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Looms Over Tenax Therapeutics Investors

Shareholders in the Crosshairs Every once in a while, the market serves up a cold dish of reality, and folks owning Tenax Therapeutics (NASDAQ:TENX) are facing just that. A class action is casting a long shadow, targeting those who bought in between November 13, 2023, and August 7, 2026. It's the kind of headache that no investor wakes up hoping for. The Allegations: When...

InsCorp's Steady Q3 Climb Mirrors Strategic Focus

Riding the Revenue Wave Now we're talking about a bank knowing their business—InsCorp, Inc. recently flaunted a 12% year-on-year revenue bump for 3Q26, a testament to a strategy that's clearly sticking. Still, while those numbers are nice and shiny, the detailed breakdown shows earnings per share (EPS) barely budged from last quarter, coming in at $0.73, just a hair...

Jewelry Repair and Resizing Demystified by Expert

The Magic of Fixing Sparkles When it comes to keeping those sparkly trinkets as charming as ever, nothing beats a well-timed fix-up. Jewelry repair isn’t just about patching up old necklaces or battered rings; it’s an art of bringing worn-out pieces back to life. I’m talking about the sort of work that Mike Littlejohn at Carbaugh Jewelers breaks down in a recent...

AbbVie's Q3 2026: Strong Performance and Bold Moves

A Deep Dive into AbbVie's Q3 2026 Numbers Bruised and battered from the ebbs and flows of the market, AbbVie (NYSE:ABBV) decided to show up in swagger mode for the third quarter of 2026. They doubled their diluted EPS year over year with a GAAP figure hitting $2.37, backed by an adjusted EPS of $3.82. You're seeing the fruits of savvy expansions and a portfolio that seems...

TDS and Array Set for Q3 Results Amid Market Curiosity

The Anticipation Builds for TDS and Array's Q3 Results Financial markets are buzzing like a caffeine-fueled trading floor about the upcoming third quarter results from Telephone and Data Systems, Inc. (NYSE: TDS) and its partner in digital endeavors, Array Digital Infrastructure, Inc. (NYSE: AD). Set to go live with their numbers on November 6, 2026, these companies are...

Ensign Lawsuit Deadline Looms: Investors, Wake Up!

A Storm Brewing in Healthcare Here's what will make any half-savvy investor's pulse quicken: The Ensign Group, Inc. (NasdaqGS: ENSG) is in hot legal water, and there's a hefty class action floating around with some serious allegations. ClaimsFiler's got the word out, marking December 7, 2026, as the cut-off date for investors wanting to be part of this securities class...

Holiday Shoppers Eye Payment Options Amid Tight Budgets

Shoppers Feel the Squeeze As Holidays Approach Hope you brought your umbrella because the holiday season is going to be awash with financial strain and stress for many consumers. According to the latest ETA-TSG Consumer Holiday Spending Study, 44% of consumers are more financially stressed this year compared to last, and the numbers aren't getting any rosier from there....

ACR Poker's $650K Mystery PKO Tournaments Heat Up

Final Countdown for ACR Poker’s Halloween Bash When it comes to poker, there might not be a better mix of tension and thrill than a big bounty tournament, and ACR Poker’s $650K Halloween Special Mystery PKOs are right in the thick of it. We’re down to the wire with just the final starting flights left, and the action’s ready to blow the lid off come November 1....

BingX's AI Enjoys Roaring Adoption in Trading

Traders and their AI tools—sounds like a match made in market heaven, right? That's the buzz coming out of BingX, the multi-asset trading platform that's been shaking things up in the fintech realm. These days, it seems like everyone's hitching a ride on the AI train. Explosive Growth in AI Utilization Now, let's talk numbers, and boy, are these numbers juicy. Daily...

Gooru AI Unveils Platform to Scale Human Expertise

A New Wave of AI-Powered Solutions Hot off the press, Gooru AI's recent shindig in the heart of Dallas aimed to showcase something they call 'Digital Goorus.' Now that might sound like a newage tech gimmick but peel back the layers and you find an ambitious attempt to let folks spread their smarts without having to be everywhere all at once. Imagine being able to crack...